Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-12

Clinical Trial Update: Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients

View source ↗

Summary

This completed trial evaluated the anti-ischemic effects of abciximab in patients undergoing angioplasty and stenting for coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ReoPro (abciximab)

Snippet

Sponsor: Emory University | Conditions: Coronary Artery Disease | Status: COMPLETED